Southlake, Texas, Feb. 07, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also…
Israeli patent covers a country known as a hotbed for medical device innovation Southlake, Texas, Feb. 06, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”),…
Granted Korean Patent for its MyoVista® Wavelet Technology Southlake, Texas, Feb. 03, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused…
To see the video, follow the link: https://proactiveinvestors.com/companies/news/1004693/heartsciences-using-technology-to-help-make-lifesaving-ecg-s-better-using-artificial-intelligence-1004693.html?viewSource=SkyAlphabet
Southlake, Texas, Jan. 20, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also…
Southlake, TX, Jan. 04, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also…
